CEL-SCI CORP reports a Return on Equity (ROE) of -330.21%.

What is CVM's dividend yield?

CEL-SCI CORP offers a dividend yield of 0.00%.

What is CVM's Deepscope Quality Score?

Deepscope rates CVM's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CVM?

Deepscope's AI Timing Score for CVM is 28 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does CVM belong to?

CEL-SCI CORP is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.

หุ้น CVM (NYSE MKT) | CEL-SCI CORP – วิเคราะห์โดย Deepscope

Stock Check ข้อมูลอัปเดตรายวัน ที่เวลา 09.30 น.
(Price: 2026-06-05 | FS: 2026-03-31)

CVM

CEL-SCI CORP

US:NYSE MKT STOCK Healthcare >> Biotechnology News 77

USD 1.37

-0.16 (-10.46%) Day Change

Watchlist Portfolio Compare Chart

0.38

D/E

-330.2%

ROE

-128.2%

ROA

0.00%

Div Yield

CEL-SCI CORP
TYPE: STOCK
MARKET: NYSE MKT

Compare Watchlist Myport

USD 1.37 Price -0.16 (-10.46%) Day Change	NEWS SCORE: 77

CVM มีคุณภาพโดยรวมไม่ดี ( คะแนนปัจจัยพื้นฐาน = 46) และ จังหวะเข้าซื้อ ...(ล็อกอินเพื่อดู)...

Loading chart...

46 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: อัตราผลตอบแทนผู้ถือหุ้น (ROE) ค่อนข้างต่ำ
อัตราผลตอบแทนสินทรัพย์ (ROA) ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ในอดีต ค่อนข้างต่ำ
อัตราผลตอบแทนผู้ถือหุ้น (ROE) ลดลงอย่างมีนัยยะสำคัญ
อัตราการเติบโตของอัตราผลตอบแทนสินทรัพย์(ROA) ปัจจุบันต่ำกว่าเกณฑ์
อัตรากำไรสุทธิ ค่อนข้างต่ำ
อัตราเร่งของการเติบโตของอัตรากำไรสุทธิ ต่ำกว่าเกณฑ์

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

ถ้าดูอย่างละเอียดจะพบว่า ปัจจัยทางคุณภาพ ไม่ดี สุขภาพทางการเงิน ยังไม่ดีนัก และ ประสิทธิภาพการทำกำไร ไม่ดี , ...

ปัจจัยทางคุณภาพ

42%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	77
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	1.37
PBV / Sector	3.23 / 4.63
Earning Per Share	-1.40

PE / Sector	N/A / 17.43
PEG or PE/Growth / Sector	N/A / 0.53
Average 1M Daily Value	1.02 M GREAT
Average 1W Daily Value	0.30 M GREAT

ปัจจัยทางเทคนิค

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

สุขภาพทางการเงิน

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ประสิทธิภาพการทำกำไร

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / 449.48
NPM Average (%) / Sector	N/A / -1,506.49
NPM Change Average (%) / Sector	N/A / 4,940.99
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-128.20 / 30.58
ROA Average (%) / Sector	-99.99 / -347.17
ROA Change Average (%) / Sector	16.65 / 5,125.52 GOOD
ROE (%) / Sector	-330.21 / -3.58
ROE Average (%) / Sector	-212.51 / 40.65
ROE Change Average (%) / Sector	43.69 / 2,109.80 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

ผลตอบแทนต่อผู้ถือหุ้น

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 4.17

รายละเอียดการจดทะเบียน

Analyze Date	2026-06-06 09:08:23
Symbol	CVM
Name	CEL-SCI CORP
Sector	Healthcare >> Biotechnology
Market	NYSE MKT
Listed Shares	14.49 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	22.17 / 8,857.28

ข่าว, ประมาณการ, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 8229 Boone Boulevard, Vienna, VA, United States, 22182

Phone: 703 506 9460

Website: https://cel-sci.com

Sector: Healthcare >> Biotechnology

Description: CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.